Dr. Heloisa Soares
Claim this profileHuntsman Cancer Institute/University of Utah
About Heloisa Soares
Education:
- Earned an MD from the Federal University of Rio de Janeiro, Brazil (2007).
- Completed Residency in Internal Medicine at the University of São Paulo, Brazil (2008-2010).
- Undertook a Fellowship in Hematology and Oncology at the University of São Paulo, Brazil (2011-2013).
- Completed a Postdoctoral Research Fellowship at the Huntsman Cancer Institute/University of Utah (2014-2016).
Experience:
- Has been an Assistant Professor of Internal Medicine at the Huntsman Cancer Institute/University of Utah since 2016.
- Specializes in cancer research with a focus on hematology and oncology.
Area of expertise
Neuroendocrine Tumors
Heloisa Soares has run 7 trials for Neuroendocrine Tumors. Some of their research focus areas include:
Pancreatic Cancer
Heloisa Soares has run 7 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
Huntsman Cancer Institute/University Of Utah
Farmington Health Center
Clinical Trials Heloisa Soares is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting
1 award
Phase 2 & 3
10 criteria
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting
2 awards
Phase 3
12 criteria
More about Heloisa Soares
Clinical Trial Related
4 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Heloisa Soares has experience with
- Lutetium Lu 177 Dotatate
- Capecitabine
- Temozolomide
- Atezolizumab
- Bevacizumab
- Everolimus
Breakdown of trials Heloisa Soares has run
Neuroendocrine Tumors
Pancreatic Cancer
Carcinoid Tumor
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Heloisa Soares specialize in?
Heloisa Soares focuses on Neuroendocrine Tumors and Pancreatic Cancer. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are SSTR positive.
Is Heloisa Soares currently recruiting for clinical trials?
Yes, Heloisa Soares is currently recruiting for 6 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Heloisa Soares has studied deeply?
Yes, Heloisa Soares has studied treatments such as Lutetium Lu 177 Dotatate, Capecitabine, Temozolomide.
What is the best way to schedule an appointment with Heloisa Soares?
Apply for one of the trials that Heloisa Soares is conducting.
What is the office address of Heloisa Soares?
The office of Heloisa Soares is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.